TNF and glioblastoma: Activation of IFN-DCs derived from glioblastoma patients with rIL-2 and dsDNA increased the expression of TNF-family mediators of receptor-dependent cytotoxicity (FasL and TRAIL), as well as granule-dependent cytotoxicity (Figure 6d).